Febuxostat and Padcev drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Febuxostat (febuxostat) and Padcev (enfortumab vedotin-ejfv). Common drug interactions include hyperglycaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Febuxostat and Padcev. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Febuxostat?

Febuxostat has active ingredients of febuxostat. eHealthMe is studying from 9,693 Febuxostat users. Check the latest studies of Febuxostat.

What is Padcev?

Padcev has active ingredients of enfortumab vedotin-ejfv. eHealthMe is studying from 2,538 Padcev users. Check the latest studies of Padcev.

On Jul, 14, 2026

29 people who take Febuxostat and Padcev together, and have interactions are studied.

Febuxostat and Padcev drug interactions.

What are the common drug interactions of Febuxostat and Padcev, by gender? *:

female:

n/a

male:

Hyperglycaemia (high blood sugar)
Myelosuppression (a decrease in the production of blood cells)
Alopecia (absence of hair from areas of the body)
Circulatory collapse
Renal failure (kidney dysfunction)
Respiratory failure (inadequate gas exchange by the respiratory system)
Sepsis (a severe blood infection that can lead to organ failure and death)
Hypoaesthesia (reduced sense of touch or sensation)
Malignant neoplasm progression (cancer tumour came back)
Dry eye (lack of adequate tears)

What are the common drug interactions of Febuxostat and Padcev, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Hyperglycaemia (high blood sugar)
Myelosuppression (a decrease in the production of blood cells)
Alopecia (absence of hair from areas of the body)
Circulatory collapse
Renal failure (kidney dysfunction)
Respiratory failure (inadequate gas exchange by the respiratory system)
Sepsis (a severe blood infection that can lead to organ failure and death)
Hypoaesthesia (reduced sense of touch or sensation)
Malignant neoplasm progression (cancer tumour came back)
Dry eye (lack of adequate tears)

What are the existing conditions these people have? *

Hyperuricaemia (level of uric acid in the blood that is abnormally high): 13 people, 44.83%
Transitional Cell Carcinoma (cancer tumour inner most layer of urinary system): 12 people, 41.38%
High Blood Pressure: 11 people, 37.93%
Bladder Cancer: 8 people, 27.59%
Hyperglycemia (high blood sugar): 7 people, 24.14%
Ureteric Cancer: 6 people, 20.69%
Dyslipidaemia (abnormal amount of lipids): 6 people, 20.69%
Constipation: 5 people, 17.24%
Rashes (redness): 5 people, 17.24%
Malignant Neoplasm Of Renal Pelvis (cancer tumour of ureter): 5 people, 17.24%

* Approximation only. Some reports may have incomplete information.

Do you take Febuxostat and Padcev?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously